Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
59°
Mostly Cloudy
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
All News
Headline News
Benzinga
Chartmill
The Motley Fool
InvestorPlace
Investor's Business Daily
MarketBeat
MarketMinute
StockStory
Stocktwits
Talk Markets
Press Releases
24-7 Press Release
AB Newswire
ACCESS Newswire
ACN Newswire
Actusnews Wire
Authority Press Wire
Binary News Network
Brandpoint
Business Wire
CannabisNewsWire
CryptoCurrencyWire
Equities.com
eTrendy Stock
FinancialNewsMedia
First Publisher
Get News
getfeatured.news
GlobePRwire
Globe NewsWire
InvestorBrandNetwork
JCN Newswire
Law Firm Newswire
MediaOutReach
MerxWire
NewMediaWire
News Direct
Newsfile
NewsUSA
Newswire.com
PR Underground
Press Advantage
Press Release Distribution Service
PressReach
PRLeap
PRLog
Prodigy
ReleaseWire
Small Business Trendsetters
Send2Press
StatePoint
TheNewswire
Worldnewswire
Zexprwire
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
September 02, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Seer Appoints Isaac Ro to its Board of Directors
September 02, 2025
From
Seer, Inc.
Via
GlobeNewswire
Tickers
SEER
WGS
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
September 02, 2025
From
Monte Rosa Therapeutics, Inc.
Via
GlobeNewswire
Tickers
GLUE
Editas Medicine Nominates EDIT-401, an LDLR-Targeted Medicine, as Lead In Vivo Development Candidate
September 02, 2025
From
Editas Medicine, Inc.
Via
GlobeNewswire
Tickers
EDIT
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
September 02, 2025
From
Verrica Pharmaceuticals Inc.
Via
GlobeNewswire
Tickers
VRCA
Atea Pharmaceuticals to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
September 02, 2025
From
Atea Pharmaceuticals, Inc.
Via
GlobeNewswire
Tickers
AVIR
eToro Group to Participate in Upcoming Investor Conferences and Reports Selected July and August Business Metrics
September 02, 2025
From
eToro Group Ltd.
Via
GlobeNewswire
Tickers
ETOR
Transom Capital-Backed Ampure Acquires Power Designers Sibex
September 02, 2025
From
Transom Capital Group
Via
GlobeNewswire
2025 CIFTIS -- What to expect: the health and medical services theme
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
Universal Safety Products, Inc. Declares One-Time Special Cash Dividend of $1.00 per Share of Common Stock
September 02, 2025
From
Universal Safety Products, Inc.
Via
GlobeNewswire
2025 CIFTIS: Bank of China highlights upcoming "Mifang Card" and AI financial innovations
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
2025 CIFTIS: Beijing to showcase green innovation in environmental services
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
Smart housing for global markets: Technology-driven solutions to launch at 2025 CIFTIS
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
Powering a Zero-Waste Future: AI Waste-to-Energy Tech to Showcase at 2025 CIFTIS
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
NorthWest Announces Drilling Underway at Kwanika
September 02, 2025
From
NorthWest Copper Corp.
Via
GlobeNewswire
Tickers
NWCCF
TSX-V:NWST
Strawberry Fields REIT Announces Acquisition of $5.3 Million Skilled Nursing/Assisted Living Facility in Missouri
September 02, 2025
From
Strawberry Fields REIT
Via
GlobeNewswire
Tickers
STRW
FTAI Aviation Ltd. to Participate in the Deutsche Bank 15th Annual Aviation Forum
September 02, 2025
From
FTAI Aviation Ltd.
Via
GlobeNewswire
Tickers
FTAI
AI-Powered "Smart Brain" Platform to be Showcased at CIFTIS 2025
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
Sports services to be showcased at 2025 CIFTIS from Sept. 10-14
September 02, 2025
From
2025 CIFTIS
Via
GlobeNewswire
Wag! Group Co. Successfully Completes Pre-Packaged Chapter 11 Plan of Reorganization
September 02, 2025
From
Wag! Group Co.
Via
GlobeNewswire
MoneyHero Group to Announce Second Quarter 2025 Results
September 02, 2025
From
MoneyHero Limited
Via
GlobeNewswire
Tickers
MNY
McEwen Reports Attractive Gold Intercepts at Grey Fox; Results Support Resource Growth Ahead of Upcoming Resource Estimate; Gibson: 10.1 g/t Gold Over 5.8 m (25GF-1597) and 10.4 g/t Gold Over 5.6 m (25GF-1564), GFS: 4.8 g/t Gold Over 14.9 m (25GF-1575)
September 02, 2025
From
McEwen Inc.
Via
GlobeNewswire
Tickers
MUX
TSX:MUX
USAA Savings Bank Selects Quavo Fraud & Disputes to Strengthen Compliance and Modernize Dispute Resolution
September 02, 2025
From
Quavo
Via
GlobeNewswire
Military Veterans Join Virtue Recovery to Expand Community Outreach with Hope and Support
September 02, 2025
From
Virtue Recovery Center
Via
GlobeNewswire
MEXC’s Q2 Zero-Fee Strategy Delivers Record Growth in High-Demand Pairs
September 02, 2025
From
MEXC
Via
GlobeNewswire
Zymeworks Announces Decision to Discontinue Clinical Development of ZW171, a Mesothelin-directed T cell Engager
September 02, 2025
From
Zymeworks Inc.
Via
GlobeNewswire
Tickers
ZYME
$152 Billion and Rising: New Report Shows Insurance Industry Facing Growing Average Annual Losses from Natural Catastrophes
September 02, 2025
From
Verisk Analytics, Inc.
Via
GlobeNewswire
Tickers
VRSK
Huize Holding Limited to Report Second Quarter 2025 Financial Results on September 12, 2025
September 02, 2025
From
Huize Holding Limited
Via
GlobeNewswire
Tickers
HUIZ
OBI Pharma Announces Phase 1/2 Study Initiation for OBI-902, a TROP2 Targeted Antibody-Drug Conjugate Therapy (ADC) in Advanced Solid Tumors
September 02, 2025
From
OBI Pharma Inc.
Via
GlobeNewswire
Fortuna to present at Mining Forum Americas 2025 in Colorado Springs, USA
September 02, 2025
From
Fortuna Mining Corp.
Via
GlobeNewswire
Tickers
FSM
TSX:FVI
< Previous
1
2
...
17
18
19
20
21
22
23
24
25
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.